Recital 4, Regulation (EU) 2022/634

In forcesince 13 Apr 2022

In accordance with Article 3 of Regulation (EC) No 470/2009, on 3 December 2019, Huvepharma N.V. submitted an application for the extension of the existing entry for bambermycin to chicken tissues to the European Medicines Agency (‘Agency’).